Abstract
National Cancer Institute
Application Receipt/Submission Date(s): Multiple dates, see announcement.
This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to independent faculty cancer research positions. This goal is achieved by providing protected time through salary and research support for the initial 3 years of the first independent tenure-track faculty position, or its equivalent, beginning at the time when the candidate starts a tenure-track faculty position.
Complete details available at: http://grants.nih.gov/grants/guide/pa-files/PAR-15-056.html.
Nci Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08): Par-15-060
National Cancer Institute
Application Receipt/Submission Date(s): Multiple dates, see announcement.
The purpose of the NCI Mentored Clinical Scientist Career Development Award (K08) program is to prepare individuals for careers that have a significant impact on the health-related research needs of the nation. This program represents the continuation of a long-standing NIH program that provides support and protected time to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in the fields of biomedical and behavioral research, including translational research. The NCI-sponsored K08 award is specifically designed to promote career development of clinical scientists from diverse backgrounds that have been shown to be underrepresented in health-related science and for those who are committed to a career in basic biomedical, behavioral or translational cancer research, including research on cancer health disparities. The expectation is that through this sustained period of research career development and training, awardees will develop enhanced research capabilities for cancer research careers and be better prepared to compete for research project grants (e.g. R03, R21, or R01) funding.
Complete details available at: http://grants.nih.gov/grants/guide/pa-files/PAR-15-060.html.
Nci Mentored Patient-Oriented Research Career Development Award to Promote Diversity (K23): Par-15-062
National Cancer Institute
Application Receipt/Submission Date(s): Multiple dates, see announcement.
The NCI's Diversity Training Branch (DTB) and the Center to Reduce Cancer Health Disparities (CRCHD) announce the availability of the “Mentored Patient-Oriented Research Award to Promote Diversity” for career development of individuals with a health professional doctoral degree from groups currently underrepresented on a national level in the biomedical, clinical, behavioral, and social sciences. The NCI recognizes a unique and compelling need to promote diversity in the patient-oriented research workforce.
Complete details available at: http://grants.nih.gov/grants/guide/pa-files/PAR-15-062.html.
Nci Transition Career Development Award to Promote Diversity (K22): Par-15-063
National Cancer Institute
Application Receipt/Submission Date(s): Multiple dates, see announcement.
The Diversity Training Branch (DTB), the Center to Reduce Cancer Health Disparities (CRCHD) (http://crchd.cancer.gov/) invites applications from recipients of the NCI Mentored Career Development Award to Promote Diversity, or from advanced postdoctoral and/or newly independent research scientists who are from backgrounds underrepresented in biomedical, behavioral, clinical, and/or social sciences. This award provides “protected time” through salary and research support for the initial 3 years of the first independent tenure-track faculty position, or its equivalent. Appropriate K22 applications are expected, but not required, to address problems that are pertinent to cancer health disparities and the biology, etiology, pathogenesis, prevention, diagnosis, control, and/or treatment of human cancer.
Complete details available at: http://grants.nih.gov/grants/guide/pa-files/PAR-15-063.html.
Nci Mentored Research Scientist Development Award to Promote Diversity (K01): Par-15-064
National Cancer Institute
Application Receipt/Submission Date(s): Multiple dates, see announcement.
The purpose of the NCI Mentored Research Scientist Development Award (K01) is to enhance the diversity of the NCI-funded cancer research workforce by supporting eligible individuals from groups that have been shown to be underrepresented in the biomedical, behavioral, social and clinical sciences. This FOA provides salary and research support for a sustained period of “protected time” for intensive research career development under the guidance of an experienced mentor, or sponsor. The Diversity Training Branch (DTB) of the Center to Reduce Cancer Health Disparities (CRCHD), at the National Cancer Institute (NCI), invites career development award applications (K01) from individuals from backgrounds that have been shown to be underrepresented in health-related science.
Complete details available at: http://grants.nih.gov/grants/guide/pa-files/PAR-15-064.html.
Niddk Multi-Center Clinical Study Cooperative Agreement (U01): Par-15-067
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt/Submission Date(s): Multiple dates, see announcement.
This FOA invites applications for investigator-initiated, multi-center clinical studies. Proposed studies should be hypothesis-driven and focus on a disease relevant to the mission of NIDDK. Planning activities must be completed prior to submission and are not permitted under this FOA. Applicants who require a planning phase may first apply for an implementation planning cooperative agreement (U34; see PAR-15-068). Consultation with NIDDK Scientific/Research staff is strongly encouraged prior to the submission of either a U34 or U01 application.
Complete details available at: http://grants.nih.gov/grants/guide/pa-files/PAR-15-067.html.
Niddk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34): Par-15-068
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt/Submission Date(s): Application Due Date(s): February 19, 2015; June 17, 2015; April 18, 2016; January 20, 2017; June 19, 2017 AIDS Application Due Date(s): February 19, 2015; September 7, 2015; May 7, 2016; January 20, 2017; September 7, 2017
NIDDK supports investigator-initiated, multi-center (three or more sites) clinical studies through a two-part process that may include an implementation planning cooperative agreement (U34). The U34 is designed to: (1) Permit early peer review of the rationale for the proposed clinical study; (2) Permit assessment of the design and protocol of the proposed study; (3) Provide support for the development of documents needed for the conduct of the study, including a manual of operations; and (4) Support the development of other essential elements required for the conduct of a clinical study. The proposed clinical study should be hypothesis-driven and focus on a disease relevant to the mission of NIDDK. Consultation with NIDDK Scientific/Research staff is strongly encouraged prior to the submission of the U34 application.
Complete details available at: http://grants.nih.gov/grants/guide/pa-files/PAR-15-068.html.
Niams Skin Biology and Diseases Resource-Based Centers (P30): Rfa-Ar-16-003
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): June 11, 2015
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Resource-based Centers Program (P30) for skin biology and diseases research areas within its mission. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on skin biology and diseases, enabling them to conduct their independently-funded individual and/or collaborative research projects more efficiently and/or more effectively, with the broad overall goal of accelerating, enriching, and enhancing the effectiveness of ongoing basic, translational, and clinical research and promoting new research within the NIAMS mission.
Complete details available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-AR-16-003.html.
New Technologies for Viral Hepatitis Sttr (R41/R42): Pa-15-076
National Institute of Diabetes and Digestive and Kidney Diseases
National Heart, Lung, and Blood Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Date(s): Multiple dates, see announcement.
The purpose of this Funding Opportunity Announcement (FOA) is to encourage small business companies to address viral hepatitis research opportunities as delineated in the Department of Health and Human Services Action Plan for the Prevention, Care and Treatment of Viral Hepatitis and within the research missions of the participating institutes.
Complete details available at: http://grants.nih.gov/grants/guide/pa-files/PA-15-076.html.
New Technologies for Viral Hepatitis Sbir (R43/R44): Pa-15-077
National Institute of Diabetes and Digestive and Kidney Diseases
National Heart, Lung, and Blood Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Date(s): Multiple dates, see announcement.
The purpose of this Funding Opportunity Announcement (FOA) is to encourage small business companies to address viral hepatitis research opportunities as delineated in the Department of Health and Human Services Action Plan for the Prevention, Care and Treatment of Viral Hepatitis and within the research missions of the participating institutes.
Complete details available at: http://grants.nih.gov/grants/guide/pa-files/PA-15-077.html.
Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment (R01): Par-15-075
National Cancer Institute
Application Receipt/Submission Date(s): The first due date for all types of applications allowed for this FOA is March 6, 2015. Thereafter Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
This Funding Opportunity Announcement (FOA) encourages applications from research partnerships formed by academic and industrial investigators, to accelerate the translation of technologies, methods, assays or devices, and/or systems for preclinical or clinical molecular diagnosis or in vitro imaging that are designed to solve a targeted cancer problem. The proposed systems may include molecular diagnosis, molecular imaging or related research resources. Funding may be requested to enhance, adapt, optimize, validate, and otherwise translate the following examples, among others: (a) current commercially supported systems, (b) next-generation systems, (c) quality assurance and quality control, (d) validation and correlation studies, (e) quantitative imaging, and (f) related research resources. Because applications should be translational in scope, this FOA defines innovation as a coherent translational plan to deliver emerging or new capabilities for preclinical or clinical use that are not yet broadly employed in preclinical or clinical settings. In addition, innovation may be considered as delivery of a new capability to end users. The partnership on each application should establish an inter-disciplinary, multi-institutional research team to work in strategic alliance to implement a coherent strategy to develop and translate their system to solve their chosen cancer problem. This FOA will support clinical trials that test functionality, optimize, and validate the performance of the proposed translational work. This FOA does not intend to support either actual commercial production or basic research projects that do not emphasize translation.
Complete details available at: http://grants.nih.gov/grants/guide/pa-files/PAR-15-075.html.